18 results
P
hyperthyroidism
I/C
Jiawei-Xiaoyao-San (JWXYS), antithyroid drugs (ATDs)
O
free triiodothyronine (FT3), free thyroxine (FT4), thyroid stimulating hormone (TSH), effectiveness rate, goiter score, thyrotrophin receptor antibody, adverse events
P
patients with poststroke depression
I/C
modified Sini San (MSS), fluoxetine hydrochloride
O
response rate, Hamilton depression rating scale (HAMD) scores, modified Edinburgh-Scandinavia stroke scale (SSS) scores
P
1335
I/C
Shen-ling-bai-zhu san (SLBZS), conventional therapies
O
superior
P
NVUGIB patients
I/C
prophylactic transcatheter arterial embolization (PTAE), control group
O
rebleeding, 30-d mortality rates, reintervention, rescue surgery, LOH, ICU stay
P
hypogonadal men
I/C
Testosterone replacement therapy (TRT), placebo
O
IIEF score
P
highly experienced hands
I/C
minimally invasive total pancreatectomy (MITP), open TP (OTP)
O
decreased estimated blood loss and transfusion rate, lower 30-day morbidity and 90-day mortality
P
African Americans, White population, Hispanic group
I/C
high temperatures, lower temperatures
O
kidney disease-related hospital admissions
P
Hispanic populations
I/C
gut microbiota related metabolites, measures of glycemia, dyslipidemia, adiposity, and incident type 2 diabetes
O
cross-sectional and longitudinal relationships
P
Patients with hepatocellular carcinoma (HCC)
I/C
Liver transplantation using different selection models: Milan, UCSF, UPTS, AFP, and MT2
O
Recurrence-free survival and overall survival rates at 1, 3, and 5 years post-transplantation
